Tracking cancer drugs in living cells by thermal profiling of the proteome
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitski et al. take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects. Science , this issue 10.1126/science.1255784
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal proteome profiling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Especially in combination with quantitative changes measured by e.g., phosphoproteomics, TPP can be used to identify functionally relevant alterations and link them to signaling and phenotypic consequences (Savitski et al, 2014; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“TPP has been used successfully in the past for drug profiling, but it generates complex data that are difficult to interpret and potentially benefit from integration with other data types (Savitski et al, 2014; Perrin et al, 2020; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Thermal stabilization (i) is leveraged in thermal proteomics profiling (TPP), an approach that has been employed to, for instance, identify the ferrochelatase FECH as a frequent off-target of kinase inhibitors,224 or to uncover leucine aminopeptidase 3 as an off-target of several HDAC inhibitors.225”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [224]
In the citing paper
“This assay is based on the concept that binding of a compound to a protein can result in thermal stabilization of the protein and-consequently-in a detectable shift of its melting curve.”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Savitski et al., 2014
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Self-citation
Cited by
Items 701–800 of 1,004
Yin, K., & Wu, R. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100560 · Cited by 7
“ligand binding (24, 25), protein–protein interactions (PPI) (26), protein post-translational modifications (27), and the organization dynamics of protein complexes (28) in living cells at the”
BackgroundA novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistance
van der Krift, F., Zijlmans, D. W., Shukla, R., Javed, A., Koukos, P. I., Schwarz, L. L. E., Timmermans‐Sprang, E. P. M., Maas, P. E. M., Gahtory, D., van den Nieuwboer, M., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302058 · Cited by 7
Dowling, P., Swandulla, D., & Ohlendieck, K. (2023) · Expert Review of Proteomics · doi:10.1080/14789450.2023.2255743 · Cited by 7
“Thermal proteome profiling (TPP) is an approach that allows specific proteins targeted by drugs to be identified, as well as applications in identifying protein-metabolite and protein– protein interactions [83].”
BackgroundStructure activity relationship and target prediction for ABX464 analogues in Caenorhabditis elegans
Shanley, H. T., Taki, A. C., Nguyen, N. H., Wang, T., Byrne, J. J., Ang, C., Leeming, M. G., Nie, S., Williamson, N. A., Zheng, Y., et al. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117540 · Cited by 7
Shanley, H. T., Taki, A. C., Nguyen, N. H., Wang, T., Byrne, J. J., Ang, C., Leeming, M. G., Williamson, N. A., Chang, B. C. H., Jabbar, A., et al. (2024) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2024.100534 · Cited by 7
“To investigate the possible protein targets of UMW-9729 in the nematode models, protein lysates of xL3s of H. contortus and L4s of C. elegans were individually incubated with 50 μ M of UMW-9729 a then subjected to TPP across a gradient of 37 ◦ ◦ S3).”
MethodInfluentialGerault, M.-A., Granjeaud, S., Camoin, L., Nordlund, P., & Dai, L. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae128 · Cited by 8
“…paper showing the coupling of quantitative mass spectrometry (MS) with CETSA has demonstrated the power of MS-CETSA (also known as thermal proteome profiling, TPP) to systematically measure drug–target engagement and identify markers of drug efficacy and toxicity at the proteomic level [7].”
BackgroundSelf-citationIsocyanides inhibit bacterial pathogens by covalent targeting of essential metabolic enzymes
Geißler, A., Junca, H., Kany, A. M., Daumann, L. J., Hirsch, A. K. H., Pieper, D. H., & Sieber, S. A. (2024) · Chemical Science · doi:10.1039/d4sc01940g · Cited by 11
Beusch, C. M., Braesch-Andersen, K., Felldin, U., Sabatier, P., Widgren, A., Bergquist, J., Grinnemo, K., & Rodin, S. (2025) · Communications Biology · doi:10.1038/s42003-025-07515-z · Cited by 9
Huber, K. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2295 · Cited by 10
Target engagement approaches for pharmacological evaluation in animal models
Kath, J. E., & Baranczak, A. (2019) · Chemical Communications · doi:10.1039/c9cc02824b · Cited by 8
Applicability of Chromatographic Co‐Elution for Antibiotic Target Identification
Schäkermann, S., Wüllner, D., Yayci, A., Emili, A., & Bandow, J. E. (2020) · PROTEOMICS · doi:10.1002/pmic.202000038 · Cited by 7
Solovyeva, E. M., Bubis, J. A., Tarasova, I. A., Lobas, A. A., Ivanov, M. V., Nazarov, A. A., Shutkov, I. A., & Gorshkov, M. V. (2022) · Biochemistry (Moscow) · doi:10.1134/s000629792211013x · Cited by 8
“In particular, for a single “drug-to-proteome” model, realization of the TPP method requires about 100 proteome-wide analyses, which is translated to the extended instrumentation time limiting wide acceptance of the method in practice.”
BackgroundInfluentialProfiling protein targets of cellular toxicant exposure
Genereux, J. C. (2023) · Molecular Omics · doi:10.1039/d2mo00246a · Cited by 8
Xu, M., Ma, X., Ye, Z., Wang, F., Xu, S., & Zhang, C. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00550 · Cited by 7
Wang, X., Chen, C., He, Y., Ding, L., Wu, Y., Huang, C., Wu, J., Ding, R., Xue, Y., Lin, Z., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202303656 · Cited by 7
Clickable Photoreactive ATP-Affinity Probe for Global Profiling of ATP-Binding Proteins
Wang, Z., Tan, J., Li, M., Gao, C., Li, W., Xu, J., Guo, C., Chen, Z., & Cai, R. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c02694 · Cited by 7
“Structuromics”: another step toward a holistic view of the cell
Levy, E. D., & Vogel, C. (2021) · Cell · doi:10.1016/j.cell.2020.12.030 · Cited by 7
Gubat, J., Selvaraju, K., Sjöstrand, L., Singh, D. K., Turkina, M. V., Schmierer, B., Sabatier, P., Zubarev, R. A., Linder, S. T., & D’Arcy, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852980 · Cited by 7
“org 8 Identification of b-AP15 Targets Using Proteomics We used Proteome Integral Solubility Alteration (PISA) (50), the high-throughput proteome-wide implementation of thermal proteome profiling (TPP) or MS-CETSA (51) to search for b-AP15 targets (Figure7A).”
MethodHalder, V., Oeljeklaus, J., Heilmann, G., Krahn, J. H., Liu, Y., Xiong, Y., Schlicht, M., Schillinger, J., Kracher, B., Ehrmann, M., et al. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201802647 · Cited by 7
Technical aspects of megaureter repair.
Hendren, W. H. (1977) · PubMed · Cited by 9
In-depth characterization of Staurosporine induced proteome thermal stability changesPreprint
Chernobrovkin, A. L., Lengqvist, J., Körner, C. C., Amadio, D., Friman, T., & Molina, D. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.13.990606 · Cited by 7
Self-citationAdsorption of bile acids by sucralfate, antacids, and cholestyramine in vitro.
Ståhlberg, M., Jalovaara, P., Laitinen, S. T., Mokka, R., Hentilä, R., Järvensivu, P., & Kairaluoma, M. V. (1987) · PubMed · Cited by 7
Mapping the GALNT1 substrate landscape with versatile proteomics toolsPreprint
Saei, A. A., Lundström, S. L., Lyu, H., Gharibi, H., Lu, W., Fang, P., Zhang, X., Meng, Z., Wang, J., Gaetani, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.24.505189 · Cited by 7
Evaluating signaling pathway inference from kinase-substrate interactions and phosphoproteomics dataPreprint
Garrido‐Rodríguez, M., Potel, C. M., Burtscher, M. L., Becher, I., Rodríguez-Mier, P., Müller‐Dott, S., Savitski, M. M., & Sáez-Rodríguez, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.21.619348 · Cited by 7
“Incorporating these proteins into our methods will require the ability to measure their functional changes at scale, potentially through functional proteomics techniques like thermal proteome profiling 34–36 .”
MethodSelf-citationIshii, M., Ludzia, P., Marcianò, G., Allen, W., Nerusheva, O. O., & Akiyoshi, B. (2022) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-07-0269-t · Cited by 5
“The bands were subjected to in-gel digestion with trypsin (Savitski et al. , 2014).”
SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis
Murga, M., López-Pernas, G., Soliva, R., Fueyo‐Marcos, E., Amor, C., Faustino, I., Serna, M., Serrano, A. G., Díaz, L., Martı́nez, S., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07106-6 · Cited by 6
“TPP enables the systematic assessment of proteins that change their physical properties in the presence of a chemical, thereby highlighting the cellular pathways affected by the drug [22].”
BackgroundSelf-citationFunctional proteoform group deconvolution reveals a broader spectrum of ibrutinib off-targets
Leo, I. R., Kunold, E., Audrey, A., Tampere, M., Eirich, J., Lehtiö, J., & Jafari, R. (2025) · Nature Communications · doi:10.1038/s41467-024-54654-8 · Cited by 8
Self-citationZhang, S., Li, F., Wang, J., Dong, Y. J., Luo, J.-F., Huang, X., Li, Y., Zhu, G., Qi, S. N., Shen, H., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.106843 · Cited by 6
“It is widely used in drug target deconvolution and off-target research [11, 13].”
Metzger, P. J., Reed, T. J., Lum, K. K., Botello, J. F., Jiang, L., Brangwynne, C. P., Troyanskaya, O. G., & Cristea, I. M. (2025) · Science Advances · doi:10.1126/sciadv.adw6814 · Cited by 11
Thermal proteome profiling of itaconate interactome in macrophages
Meng, Y., Wei, T., Zhang, C., Yu, A., Liu, Y., Xiao, J., & Wang, C. (2025) · Chemical Science · doi:10.1039/d5sc02378e · Cited by 6
Thermal shift assays in drug discovery – Troubleshooting from biochemical to cellular applications
Hanke, D., Brown, J. I., & Page, B. D. G. (2025) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2025.108380 · Cited by 6
Tarbox, H. E., Branch, A., & Fried, S. D. (2025) · Science Advances · doi:10.1126/sciadv.adt3778 · Cited by 9
Qin, J., Zhang, S., Pan, Y., Lei, X., Guo, Z., Xie, Q., Huang, K., & Huo, P. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11361-w · Cited by 6
“In 2014, Savitski's team combined the CETSA method with quantitative mass spectrometry (MS) to design thermal proteomics (TPP), which involves data analysis of multiple temperature points and high-throughput mass spectrometry, and the process is relatively complex [47] ( Fig.”
Lambos, J. C., Bhattacharya, A., Al‐Seragi, M., & Duong, F. (2025) · PROTEOMICS · doi:10.1002/pmic.70057 · Cited by 11
“TPP overcomes the throughput limitation of CETSA by integrating MS-based proteomics [55, 56].”
Sarkar, S., Fossen, E. M. V., Li, X., Zhang, T., Feng, S., Prozapas, V. N., Ludovico, I. D., Shouaib, A., Hutchinson, C. M., Sadler, N., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101443 · Cited by 7
“…data is reflected in the shape of the melting curves, where curves exhibiting a “proper shape” are more likely to represent a real unfolding event (33), demonstrating that the loss of protein is due to perturbation-induced changes in the melting temperature of the protein, not just changes in the…”
Regulation of RNA-binding proteins by small biomolecules
Miao, W., Porter, D. F., Lopez-Pajares, V., & Khavari, P. A. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00914-4 · Cited by 8
“Thermal proteome profiling (TPP), also known as cellular thermal shift assay coupled with mass spectrometry (CETSA-MS), has been used to study SBM-binding proteins such as ATP-binding proteins 311 , and protein inhibitors 312 .”
Wu, Z., Zou, Y., Yang, K., Yu, X., Fu, Z., Le, X. C., & Chen, J. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.140458 · Cited by 6
Mass spectrometry-based strategies for membrane protein pharmacology
Reiter, A. H., Fehr, A., Florea, R., Floyd, B. M., & Schuster, D. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.10.012 · Cited by 9
Yu, H., Chen, Y., Wu, M., Wang, W.-T., Qiu, J., Xu, R., Tong, J., Chen, Y., Liu, X., Wu, Y., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c20040 · Cited by 7
Al-Amin, R. A., Johansson, L., Abdurakhmanov, E., Landegren, N., Löf, L., Arngården, L., Blokzijl, A., Svensson, R., Hammond, M., Lönn, P., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac842 · Cited by 6
Mapping Peptide–Protein Interactions by Amine-Reactive Cleavable Photoaffinity Reagents
Korovesis, D., Gaspar, V. P., Beard, H. A., Chen, S., Zahedi, R. P., & Verhelst, S. H. L. (2023) · ACS Omega · doi:10.1021/acsomega.3c03064 · Cited by 7
Gassaway, B. M., Huttlin, E. L., Huntsman, E. M., Yaron-Barir, T. M., Johnson, J. L., Kurmi, K., Cantley, L. C., Paulo, J. A., Ringel, A. E., Gygi, S. P., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100801 · Cited by 6
“These innovations build upon previous thermal stability methods (7, 8, 12 – 18) and enable the simultaneous quanti fi cation of four biochemical properties at proteome scale: protein abundance, protein thermal stability, phosphorylation site abundance, and phosphorylation site thermal stability (Fig.”
MethodLizano-Fallas, V., del Amor, A. C., & Cristóbal, S. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.143228 · Cited by 6
Spike-In Proteome Enhances Data-Independent Acquisition for Thermal Proteome Profiling
Wang, Q., Chen, Q., Lin, Y., He, D., Ji, H., & Tan, C. S. H. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04837 · Cited by 7
Sun, Y., Li, C., Deng, X., Li, W., Deng, X., Ge, W., Shi, M., Guo, Y., Yu, Y. V., Zhou, H., et al. (2024) · eLife · doi:10.7554/elife.102667.3 · Cited by 6
Zhang, W., Li, X., Zhang, X., Dong, Y., & Hu, L. (2020) · Analytical Methods · doi:10.1039/d0ay02099k · Cited by 6
Kakegawa, J., Ohtsuka, S., Yokoyama, M., Hosoi, T., Ozawa, K., & Hatanaka, T. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000243 · Cited by 7
“The compound concentration required for the changing thermal stability tends to be about 10 times higher than that of affinity for compound binding proteins (Savitski et al., 2014).”
BackgroundMethodInfluentialSultonova, M., Blackmore, B., Du, R., Philips, O., Paulo, J. A., & Murphy, J. P. (2022) · PROTEOMICS · doi:10.1002/pmic.202100254 · Cited by 5
“Aliquots of 40 μg of protein in 40 μl of lysis buffer were subjected to thermal proteome profiling (TPP) with a temperature gradient of 43.0◦C to 59.0◦C for 3 min in a BioRad T100 thermal cycler (BioRad, Hercules, CA).”
BackgroundMethodInfluentialMass spectrometry for mitochondrial multi-omics
Wang, Z., Liu, B., Lin, L., & Qiao, L. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117063 · Cited by 8
Orthogonal Strategies for Profiling Potential Cellular Targets of Anandamide and Cannabidiol
Tang, G., Lim, Y., Wang, W., Ye, Z., Zhang, C., & Yao, S. Q. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202300682 · Cited by 7
Pharmacological approaches to understanding protein kinase signaling networks
Stephenson, E. H., & Higgins, J. M. G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1310135 · Cited by 8
Stability-Based Proteomics for Investigation of Structured RNA–Protein Interactions
Bailey, M. A., Martyr, J. G., Hargrove, A. E., & Fitzgerald, M. C. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04978 · Cited by 9
Label-Free Screening Technologies
Ye, F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12330-3 · Cited by 6
Evaluation of a Pooling Chemoproteomics Strategy with an FDA-Approved Drug Library
Sun, H., Yang, K., Zhang, X., Fu, Y., Yarbro, J. M., Wu, Z., Chen, P., Chen, T., & Peng, J. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00256 · Cited by 8
PROMIS: Co-fractionation Mass Spectrometry for Analysis of Protein–Metabolite Interactions
Luzarowski, M., Sokołowska, E., Schlossarek, D., & Skirycz, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2624-5_10 · Cited by 6
Plants and Small Molecules: An Up-and-Coming Synergy
Lepri, A., Longo, C., Messore, A., Kazmi, H., Madia, V. N., Santo, R. D., Costi, R., & Vittorioso, P. (2023) · Plants · doi:10.3390/plants12081729 · Cited by 8
Quantifying drug-target engagement in live cells using sulfonyl fluoride chemical probes
Jones, L. H., Xu, H., & Fadeyi, O. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.02.010 · Cited by 6
Epigenetic drug target deconvolution by mass spectrometry–based technologies
Noberini, R., & Bonaldi, T. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0279-x · Cited by 6
Gholizadeh, E., Khaleghian, A., Seyfi, D. N., & Karbalaei, R. (2020) · Gastroenterology and hepatology from bed to bench. · Cited by 5
Hong, K. T., & Lee, J. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00975 · Cited by 6
Multidimensional Proteomics Identifies Molecular Trajectories of Cellular Aging and RejuvenationPreprint
Leutert, M., Armstrong, J., Ollodart, A. R., Hess, K. N., Muir, M., Rodríguez‐Mias, R. A., Kaeberlein, M. R., Dunham, M. J., & Villén, J. (2023) · SSRN Electronic Journal · doi:10.1101/2023.03.09.531951 · Cited by 7
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation
Rutkowska, A., Eberl, H. C., Werner, T., Hennrich, M. L., Sévin, D. C., Petretich, M., Reddington, J. P., Pocha, S. M., Gade, S., Martínez-Segura, A., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0549 · Cited by 5
“289 and T47D cells in a two-dimensional thermal proteome profiling (2D-TPP) setting as described before (21, 22).”
Self-citationDissecting S-itaconation at host–pathogen interactions with chemical proteomics tools
Liu, Z., & Wang, C. (2025) · Current Opinion in Microbiology · doi:10.1016/j.mib.2025.102579 · Cited by 5
Jiang, N., Yang, H., Lei, Y., Qin, W., Xiong, H., Chen, K., Mei, K., Li, G., Mu, X. N., & Chen, R. (2025) · Nature Communications · doi:10.1038/s41467-025-58704-7 · Cited by 6
Wang, K., Li, Y., Ma, Y., & Ye, M. (2025) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2025.102602 · Cited by 5
Alezi, D., Iskandrani, A., Ali, E. M. M., & Babgi, B. A. (2025) · Dalton Transactions · doi:10.1039/d5dt01851j · Cited by 6
Divergent proteome tolerance against gain and loss of chromosome arms
Di, Y., Li, W., Castellano, J. J., Jin, W., Modi, J. N., Šalovská, B., Khosroabadi, D., Hu, W., Taylor, A. M., & Liu, Y. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.10.023 · Cited by 10
Progress in Natural Products Target Discovery Technology
Pan, Q., Yuan, X., Jin, J., Luan, X., Luo, C., Chen, H., Zhang, W., & Zhang, H. (2026) · MedComm · doi:10.1002/mco2.70777 · Cited by 5
Extraction of active, contaminant degrading enzymes from soil
Chacha, W. E., Tran, .-T., Scarlett, W. R., & Hutchison, J. M. (2023) · Applied Soil Ecology · doi:10.1016/j.apsoil.2023.104841 · Cited by 5
“This is especially true of extracting active proteins, which could be used in emerging proteomic analyses such as thermal shift assays (Savitski et al., 2014).”
BackgroundMerging multi-omics with proteome integral solubility alteration unveils antibiotic mode of action
Maity, R., Zhang, X., Liberati, F. R., Rossi, C. S., Cutruzzolà, F., Rinaldo, S., Gaetani, M., Aínsa, J. A., & Sancho, J. (2024) · eLife · doi:10.7554/elife.96343 · Cited by 13
Liu, Y., Wei, C., Yang, Y., Zhu, Z., Ren, Y., & Pi, R. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176930 · Cited by 6
Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells
Schmitt, L., Krings, K. S., Wolsing, A., Buqué, X., Zimmermann, M., Flores‐Romero, H., Lenz, T., Lechtenberg, I., Peter, C., Stork, B., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01913-2 · Cited by 6
“Through mass spectrometry, the thermal profiles of these affected proteins can be determined, thereby enabling the successful identification of respective drug targets [33, 34].”
Effect of Drug-to-Protein Reaction Kinetics on the Results of Thermal Proteome Profiling
Fedorov, I. I., Ivanov, M. V., & Gorshkov, M. V. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04313 · Cited by 5
Target Discovery Driven by Chemical Biology and Computational Biology
Lyu, B., Gou, W., Xu, F., Chen, L., Wang, Z., Ren, Z., Liu, G., Li, Y., & Hou, W. (2025) · The Chemical Record · doi:10.1002/tcr.202400182 · Cited by 8
Zhang, Y., Luo, Z., Jiang, Y., Zheng, L. T., Ma, L., Zheng, Y., Zou, M., Kong, L., & Wang, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117495 · Cited by 5
Discovery of RNA-Protein Molecular Clamps Using Proteome-Wide Stability Assays
Goldstein, S. I., Fan, A. C., Wang, Z., Naineni, S. K., Cencic, R., Garcia-Gutierrez, S. B., Patel, K., Huang, S., Brown, L. E., Emili, A., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c01129 · Cited by 6
Fluorescent Thermal Shift Assays for Identifying Small Molecule Ligands
Scott, A. D. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781788010016-00208 · Cited by 7
The Impact of Assay Design on Medicinal Chemistry: Case Studies
Born, J. R., Chenniappan, V. K., Davis, D., Dahlin, J. L., Marugán, J., & Patnaik, S. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211026238 · Cited by 5
Hellinen, L., Koskela, A. K. J., Vattulainen, E., Liukkonen, M., Wegler, C., Treyer, A., Handin, N., Svensson, R., Myöhänen, T. T., Poso, A., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112501 · Cited by 6
Cuevas-Cruz, M., Hernández-Guzmán, U., Álvarez-Rosales, P. C., Schnabel, M., Gómez‐Manzo, S., & Arreguín‐Espinosa, R. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220329090822 · Cited by 6
Selective chemical probes can untangle the complexity of the plant cell endomembrane system
Ma, Q., Chang, M., Drakakaki, G., & Russinova, E. (2022) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2022.102223 · Cited by 5
Proteomics contributions to epigenetic drug discovery
Noberini, R., & Bonaldi, T. (2023) · PROTEOMICS · doi:10.1002/pmic.202200435 · Cited by 5
“The same approach is often referred to as cellular thermal shift assay (CETSA)-MS, because it profiles drug-induced protein thermal stability changes—like CETSA-using a proteome-wide analysis of protein drug-proteins interaction from changes due to downstream effects [100].”
BackgroundSmall molecule activates citrullination through targeting PAD2
Zhang, X., Shen, M., Zhu, H., Zhang, J., Yang, M., Su, K., Zhang, Y., Fu, W., Ke, X., & Qu, Y. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0248 · Cited by 4
del Amor, A. C., Hernández-Bautista, R., Ussar, S., Cristóbal, S., & Urbatzka, R. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176158 · Cited by 5
Development of Biochemical and Cellular Probes to Study RIPK1 Target Engagement
Yu, X., Lin, H., Li, F., Wang, J., & Lu, D. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.4c00104 · Cited by 6
Fedorov, I. I., Bubis, J. A., Kazakova, E. M., Lobas, A. A., Ivanov, M. V., Emekeeva, D. D., Tarasova, I. A., Nazarov, A. A., & Gorshkov, M. V. (2024) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-024-05330-9 · Cited by 5
“Determination of the regulated proteins, as well as the drug targets at the entire proteome level, has become possible with the development of high-throughput high-resolution mass analyzers [3, 4] and the thermal proteome profiling approach (TPP) [5, 6].”
Exploring the Molecular Therapeutic Mechanisms of Gemcitabine through Quantitative Proteomics
Yue, J., Ren, X., Zhao, J., Liu, G., Liu, F., Guo, X., Hao, M., Liu, H., Liu, K., & Huang, H. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00890 · Cited by 6
Sueur, C. L., Rattray, M., & Savitski, M. M. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011632 · Cited by 9
Self-citationWhole/Intact Cell MALDI MS Biotyping in Mammalian Cell Analysis
Munteanu, B., & Hopf, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-04819-2_13 · Cited by 6
Screening for Target Engagement using the Cellular Thermal Shift Assay - CETSA
Axelsson, H., Almqvist, H., Seashore-Ludlow, B. A., & Lundbäck, T. (2016) · Europe PMC (PubMed Central) · Cited by 6
ATP alters protein folding and function of Escherichia coli uridine phosphorylase
Liu, Y., Lin, T.-H., & Liu, P.-F. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.09.007 · Cited by 5
Chen, Z., & Chen, J. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000356 · Cited by 6
Mass spectrometry-based technologies for probing the 3D world of plant proteins
Blackburn, M. R., Minkoff, B. B., & Sussman, M. R. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac039 · Cited by 5
STPP-UP: An alternative method for drug target identification using protein thermal stability
Zijlmans, D. W., Hernández-Quiles, M., Jansen, P. W. T. C., Becher, I., Stein, F., Savitski, M. M., & Vermeulen, M. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105279 · Cited by 5
Self-citationUltralight Ultrafast Enzymes**
Zhang, X., Meng, Z., Beusch, C. M., Gharibi, H., Cheng, Q., Lyu, H., Stéfano, L. D., Wang, J., Saei, A. A., Végvári, Á., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202316488 · Cited by 5
Evaluation of FOXO1 Target Engagement Using a Single-Cell Microfluidic Platform
Osman, S., Bendtsen, C., Peel, S. E., Yrlid, L., Muthas, D., Simpson, J., Willison, K. R., & Klug, D. R. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02808 · Cited by 5
Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer
Luxenburger, A., Bougen-Zhukov, N. M., Fraser, M. G., Beetham, H. G., Harris, L. D., Schmidt, D., Cameron, S. A., Guilford, P., & Evans, G. B. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01609 · Cited by 6
Proteome thermal stability reflects organ physiology and identifies drug-target engagement in vivoPreprint
Perrin, J., Werner, T., Kurzawa, N., Childs, D., Kalxdorf, M., Rutkowska, A., Poeckel, D., Sévin, D. C., Stonehouse, E., Strohmer, K., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/500306 · Cited by 5
“It also enables the proteome-wide assessment of drug-protein interactions by combining quantitative mass spectrometry (1) with the cellular thermal shift assay, (CETSA)(2)(3)(4).”
BackgroundMethodResultInfluentialSelf-citationRapid discovery of drug target engagement by isothermal shift assayPreprint
Webb, K. J., Ball, K. A., Coleman, S. J., Jacobsen, J. R., Stowell, M. H. B., & Old, W. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/584656 · Cited by 5
“Venn diagram of (e) iTSA 52°C and Savitski et al., 2014 staurosporine targets and (f) targets from 48°C, 52°C, and 56°C iTSA experiments.”
BackgroundMethodInfluentialLiP-Quant, an automated chemoproteomic approach to identify drug targets in complex proteomesPreprint
Piazza, I., Beaton, N., Bruderer, R., Knobloch, T., Barbisan, C., Siepe, I., Rinner, O., de Souza, N., Picotti, P., & Reiter, L. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/860072 · Cited by 5
“Thermal proteome profiling (TPP) is an unbiased approach that can identify compound binding events in a complex proteome 4-6 but it relies exclusively on alterations of a target’s thermal stability, involves complex melt curve analyses, and provides no structural information such as the compound…”
Background
Metadata
- Authors
- Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., Kuster, B., Nordlund, P., Bantscheff, M., & Drewes, G.
- Affiliations
- GlaxoSmithKline (Germany) (DE)
- Karolinska Institutet (SE)
- German Cancer Research Center (DE)
- Department of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, Freising, Germany.
- Division of Biophysics, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author
- Savitski, Mikhail M.
- Reinhard, Friedrich B. M.
- Bantscheff, Marcus
- Drewes, Gerard
- ORCID
- Venue
- Science
- Published
- 2014-10-03
- Volume
- 346
- Issue
- 6205
- Pages
- 1255784-1255784
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2131321938
- Cited by
- 1,187
- References
- 41
- Citations by year
- 2026: 119 · 2025: 138 · 2024: 148 · 2023: 130 · 2022: 116 · 2021: 132 · 2020: 95 · 2019: 85 · 2018: 67 · 2017: 56 · 2016: 54 · 2015: 39 · 2014: 5
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- thermal proteome profiling, drug-target engagement, protein thermal stability, kinase inhibitors, staurosporine, ferrochelatase, vemurafenib, alectinib, phototoxicity, dasatinib, BCR-ABL, cancer drug targets
- MeSH terms
- Adenosine Triphosphatases, Antineoplastic Agents, Hot Temperature, Humans, Ligands, Protein Binding, Protein Denaturation, K562 Cells, Proteome, Proteomics, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.